Clinical and NGS predictors of response to regorafenib in recurrent glioblastoma.
Chiesa S, Mangraviti A, Martini M, Cenci T, Mazzarella C, Gaudino S, Bracci S, Martino A, Della Pepa GM, Offi M, Gessi M, Russo R, Martucci M, Beghella Bartoli F, Larocca LM, Lauretti L, Olivi A, Pallini R, Balducci M, D'Alessandris QG.
Chiesa S, et al. Among authors: martino a.
Sci Rep. 2022 Sep 28;12(1):16265. doi: 10.1038/s41598-022-20417-y.
Sci Rep. 2022.
PMID: 36171338
Free PMC article.